# Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome

> **NCT00006174** · PHASE1 · COMPLETED · sponsor: **National Institute of Dental and Craniofacial Research (NIDCR)** · enrollment: 25 (—)

## Conditions studied

- McCune Albright Syndrome
- Polyostotic Fibrous Dysplasia
- Precocious Puberty

## Interventions

- **DRUG:** Letrozole

## Key facts

- **NCT ID:** NCT00006174
- **Lead sponsor:** National Institute of Dental and Craniofacial Research (NIDCR)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-08-03
- **Primary completion:** —
- **Final completion:** 2009-05-18
- **Target enrollment:** 25 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006174, "Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00006174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*